American Funds Bond Fund of America has been a model of consistency in recent years, except for some stumbles around interest rates worth taking in stride.
The strategy’s poor showing thus far in 2026 is reminiscent of 2023. The portfolio’s greater sensitivity to rising interest rates (as measured by duration) and its yield-curve positioning weighed on results that year. This year, interest rate sensitivity has again hurt. In the first quarter, the management team moved the portfolio from a modestly short duration position versus the Bloomberg US Aggregate Bond Index to between 0.2 and 0.36 years longer than the index. That posture was a problem in the third quarter, when interest rates for the three- to 10-year part of the Treasury curve increased between 85 and 90 basis points. Rates have fallen since, but the strategy’s year-to-date showing through early November 2026 ranked in the bottom quintile of the intermediate-core bond Morningstar Category.
The strategy’s record since Pramod Atluri became principal investment officer at the start of 2020 remains outstanding, however, thanks in large part to a measured approach to risk-taking. That includes interest rate positioning. Its duration versus the benchmark has rarely exceeded half a year, and its duration range of roughly 5.7 to 6.4 years has hovered around the category median over Atluri’s tenure. Although the strategy has struggled to anticipate and take advantage of yield curve changes, those efforts have not caused results to differ materially from those of the benchmark. In fact, the strategy’s rolling one-year tracking error versus the index, a measure of differentiation, has remained at or below the category median from 2020 through October 2026.
The strategy’s five named managers and analyst-led research portfolio excel in allocating assets to attractively valued parts of the market. Amid tightening valuations within agency mortgage-backed securities, the team cut exposure in 2026’s first three quarters while adding to the strategy’s corporate bond weighting as yield spreads in that corner of the market widened. That’s contributed to the portfolio’s yield advantage of nearly 50 basis points versus the index, as of September 2026.
Bond-picking is another strength, with big positions often being built at opportune moments, sometimes years prior. For example, the fund’s typical 2.4% high-yield bond stake as of September 2026 included a 30-basis-point stake in the debt of specialty chemicals manufacturer Celanese. Following a debt-financed acquisition and business headwinds, Celanese first lost its investment-grade credit rating in November 2024, around the time the fund’s weighting in the company increased more than fivefold, when the analyst covering Celanese then judged the credit to be oversold.
Shifts like moving away from agency MBS and toward corporate bonds and picks like Celanese have been key to this fund’s past success and should bode well for its future, occasional setbacks notwithstanding.
